Analysis and partnering services for NMPA-approved interventional medical devices from China

China Medtech Radar

SwitzerlandNew on Amplifa

SwitzerlandLocation (headquarters)

About China Medtech Radar

China Medtech Radar is a Switzerland-based information and advisory service focused on the Chinese medical device industry. The company publishes the quarterly China Interventional Device Intelligence Report, which compiles NMPA registrations of domestic Class III interventional products in the fields of cardiology, neurointervention, and peripheral vascular interventions. In addition, China Medtech Radar offers tailored research and device reports, partnering and sourcing services with direct outreach to legal manufacturers, due diligence support, and market-entry validation for investors. Target audiences are international distributors, medical device manufacturers, investors, and corporate development teams. The company positions itself as an independent partner with experience in cross-border medical device transactions and, according to its own statements, is not part of any manufacturing or supply chain; it is therefore listed on the B2B industrial marketplace as an engineering and consulting provider.

Site: Switzerland
Processes: Quarterly China Interventional Device Intelligence Report (NMPA Class III Registrations), Custom MedTech Matchmaking / Partnering & Sourcing, Due Diligence & Commercialization Support, Rapid-response custom scouting / direct outreach to legal manufacturers, Bespoke Research & Dedicated Device Reports, Market-entry validation for investors
Materials: Quarterly China Interventional Device Intelligence Report, Custom Scouting & Matchmaking, Bespoke Research & Device Reports, Due Diligence & Commercialization Support
Industries: Medical and laboratory technology, Medical device distribution, Healthcare investors / Private Equity, Interventional cardiology, Neurointervention, Peripheral vascular interventions

01
Market monitoring of NMPA registrations
02
Preparation of intelligence reports
03
Custom scouting and partner outreach
04
Due diligence and market-entry validation
05
Support for cross-border commercialization

Services and Methods

QIDIR

Quarterly China Interventional Device Intelligence Report

Quarterly report on NMPA registrations of domestic Class III interventional devices with technical evidence material, device spotlights, and register.

CSCOUT

Custom Scouting & Matchmaking

Rapid-response research on identified target technologies with direct outreach to legal manufacturers on behalf of distributors.

RESEARCH

Bespoke Research & Device Reports

Custom analyses of devices, therapy segments, regulatory pathways, and supply chains in China.

Due Diligence & Commercialization Support

Commercial assessment and market-entry validation for investors and manufacturers.

Locations

Switzerland

Headquarters / Operations

Service Offerings

**Interventional Devices (Thematic Focus)**Intelligence Report · Interventional Cardiology

Inside the production

Industries

Medical and laboratory technologyMedical device distributionHealthcare investors / Private EquityInterventional cardiologyNeurointerventionPeripheral vascular interventionsMedTechMedical device distributionMedical device manufacturers

Additional services

Quarterly China Interventional Device Intelligence Report (NMPA Class III Registrations)Custom MedTech Matchmaking / Partnering & SourcingDue Diligence & Commercialization SupportRapid-response custom scouting / direct outreach to legal manufacturersBespoke Research & Dedicated Device ReportsMarket-entry validation for investors

History

2025
First documented web presence (About page September 2025).
2025
Start of regular analyst articles, e.g. on the innovation landscape and MedTech IPOs in China (from November 2025).
2026
Launch of dedicated partnering and sourcing services as well as quarterly intelligence reports (Q1/Q2 2026).